VitaNova Life Sciences (VNOV) Other Accumulated Expenses (2019 - 2025)

VitaNova Life Sciences has disclosed Other Accumulated Expenses across 5 years of filings, most recently posting $3951.0 for Q4 2025.

• Other Accumulated Expenses for Q4 2025 came in at $3951.0, up 338.03% year-over-year; the trailing twelve-month figure through Oct 2025 was $3951.0 (up 338.03% YoY), and the FY2025 annual result was $820.0, down 90.12% from the prior year.
• Other Accumulated Expenses for Q4 2025 stood at $3951.0, up from $1226.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $28563.0 in Q2 2021 and bottomed at $820.0 in Q2 2025.
• Average Other Accumulated Expenses over 3 years is $5713.1, with a median of $2795.0 recorded in 2025.
• On a YoY basis, Other Accumulated Expenses climbed as much as 338.03% in 2025 and fell as far as 90.12% in 2025.
• Year by year, Other Accumulated Expenses stood at $28563.0 in 2021, then sank by 96.84% to $902.0 in 2024, then soared by 338.03% to $3951.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $3951.0 (Q4 2025), $1226.0 (Q3 2025), and $820.0 (Q2 2025), per Business Quant data.